Epithelial-Mesenchymal Transition and Drug Resistance in Breast Cancer (Review)

International Journal of Oncology- Greece

doi 10.3892/ijo.2015.3084

Full Text

Abstract

Available in

Date

Authors

Publisher

Spandidos Publications

Related search

Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2016English

The Importance of Epithelial-Mesenchymal Transition and Autophagy in Cancer Drug Resistance

2019English

Commentary on “Epithelial–to–Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer”

Cancer Research
Cancer ResearchOncology
2016English

Host Microenvironment in Breast Cancer Development: Epithelial–mesenchymal Transition in Breast Cancer Development

Breast Cancer Research
Cancer ResearchOncology
2003English

Interleukin-6 Induces Epithelial-Mesenchymal Transition in Breast Cancer Cells

Gaceta Mexicana de Oncolog�a
2019English

Epithelial-Mesenchymal Transition—A Hallmark of Breast Cancer Metastasis

Cancer Hallmarks
2013English

DUSP4 Promotes Doxorubicin Resistance in Gastric Cancer Through Epithelial-Mesenchymal Transition

Oncotarget
Oncology
2017English

Trail Resistance Induces Epithelial-Mesenchymal Transition and Enhances Invasiveness by Suppressing PTEN via miR-221 in Breast Cancer

PLoS ONE
Multidisciplinary
2014English

Loss of CLCA4 Promotes Epithelial-To-Mesenchymal Transition in Breast Cancer Cells

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy